SELENBP1 and neoplasm: Mechanistically, SELENBP1 was identified and experimentally validated as a putative tumor suppressor that modulates LUAD cell proliferation, migration, oxidative stress, and apoptosis, both in vitro and in vivo, underscoring its potential as a therapeutic target.